Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T13:21:33.972Z.
Calculation as of: 2026-10-06T13:21:33.972Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 47abfa0c1c9b7ee8852b85727c09e566e291b91d06fb52154cb7b2e7f04347a4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
Drugs Made In America Acquisition II Corp. Ordinary Shares
Market Cap
$649.10M
EV/EBIT Ratio
N/A
| NAME | MARKET CAP | EV/EBIT RATIO |
|---|---|---|
| Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) | $649.10M | N/A |
| ACNB Corporation (ACNB)vs › | $651.32M | N/A |
| Capital Bancorp, Inc. (CBNK)vs › | $651.85M | N/A |
| CoinShares PLC Ordinary Shares (CSHR)vs › | $637.82M | N/A |
| American Bitcoin Corp (ABTC)vs › | $635.10M | N/A |
| BlackRock Multi-Sector Income Trust (BIT)vs › | $633.40M | N/A |
| Hypoport SE (HYPOF)vs › | $630.67M | N/A |
| Gladstone Investment Corporation (GAINI)vs › | $669.58M | N/A |
| Donegal Group Inc. (DGICA)vs › | $672.06M | N/A |
| Coastal Financial Corporation (CCB)vs › | $624.44M | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
